Pershing Square Investors Getting 'Ansty' Over Herbalife (HLF) Public Debate
FOX Business Network (FBN) Senior Correspondent Charlie Gasparino reported Tuesday that investors in Bill Ackman's Pershing Square Capital hedge fund are getting "very antsy" about the public feuding over Herbalife (NYSE: HLF), including last week's epic battle with Carl Icahn that aired live on CNBC.
"His investors and we are getting this from sources close to some of the major investors, they are getting antsy," Gasparino reported. "They may redeem shares. I'm not saying they are, but they are getting very antsy about this public feuding."
Ackman is short over 20 million shares of Herbalife and is betting the stock "goes to zero." Other hedge funds, including Dan Loeb's Third Point LLC, have taken the other side of the trade and could be looking to orchestrate, as Mr. Icahn put it, "the mother of all short squeezes." Icahn declined to disclose if he was long the stock, but rumors in the market suggest he is.
"His investors and we are getting this from sources close to some of the major investors, they are getting antsy," Gasparino reported. "They may redeem shares. I'm not saying they are, but they are getting very antsy about this public feuding."
Ackman is short over 20 million shares of Herbalife and is betting the stock "goes to zero." Other hedge funds, including Dan Loeb's Third Point LLC, have taken the other side of the trade and could be looking to orchestrate, as Mr. Icahn put it, "the mother of all short squeezes." Icahn declined to disclose if he was long the stock, but rumors in the market suggest he is.